The FINANCIAL -- Female genital mutilation/cutting is a traditional practice that ranges from nicking to total removal of the external female genitalia.

The FINANCIAL -- Novartis has received a Complete Response letter from the US Food and Drug Administration  on its application for the expanded use of Menveo in infants and toddlers from 2 months of age. Menveo is already approved for use in individuals 2 to 55 years of age in the US.

The FINANCIAL -- The research-based pharmaceutical industry announced donations of 14 billion treatments this decade to support the elimination or control of nine key neglected tropical diseases,according to IFPMA.

The FINNCIAL -- Pfizer announced that the U.S. Food and Drug Administration has accepted its New Drug Application for standard review of bosutinib as a treatment option for adult patients with previously treated Philadelphia chromosome positive chronic myeloid leukemia, according to Pfizer.

The FINANCIAL -- Pharmacyclics, a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer and immune mediated diseases, announced updated results of a Phase Ib/II trial of the selective, irreversible Bruton's tyrosine kinase inhibitor, PCI-32765, for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia small lymphocytic lymphoma .